NCT03585738View on ClinicalTrials.gov

Effects of Oral Inositol Supplementation on Obstetrics Outcomes in PCOS Women

NANot yet recruitingINTERVENTIONAL
Enrollment

80

Participants

Timeline

Start Date

January 1, 2022

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2026

Conditions
Polycystic Ovary Syndrome
Interventions
DIETARY_SUPPLEMENT

Inositol + Folic acid

"Daily oral supplementation before spontaneous conception until delivery:~Myo-Inositol: 1100 mg D-chiro-inositol: 27.6 mg Folic acid: 400 mcg"

DIETARY_SUPPLEMENT

Folic acid

"Daily oral supplementation before spontaneous conception until delivery:~Folic acid: 400 mcg"

All Listed Sponsors
collaborator

Universita di Verona

OTHER

lead

Università degli Studi dell'Insubria

OTHER

NCT03585738 - Effects of Oral Inositol Supplementation on Obstetrics Outcomes in PCOS Women | Biotech Hunter | Biotech Hunter